Get the latest insights on price movement and trend analysis of Rifampicin in different regions across the world (Asia, Europe, North America, Latin America, and the Middle East & Africa).
Procurement Resource provides latest prices of Rifampicin. Each price database is tied to a user-friendly graphing tool dating back to 2014, which provides a range of functionalities: configuration of price series over user defined time period; comparison of product movements across countries; customisation of price currencies and unit; extraction of price data as excel files to be used offline.
Rifampin, often known as rifampicin, is a macrocyclic antibiotic having significant action against mycobacteria that is frequently used in conjunction with other medications to treat tuberculosis. A semi-synthetic antibiotic produced from Amycolatopsis rifamycinica, rifampicin is a member of the rifamycin family.
As an EC 22.214.171.124 (RNA polymerase) inhibitor, DNA synthesis inhibitor, antitubercular agent, leprostatic drug, Escherichia coli metabolite, protein synthesis inhibitor, neuroprotective agent, angiogenesis inhibitor, pregnancy X receptor agonist, antineoplastic agent, antiamoebic agent, and geroprotector, it also plays these other roles.
|Industrial Uses||Antibacterial medicine|
|Molecular Weight||822.9 g/mol|
|Supplier Database||Wellona Pharma, AVANSCURE LIFESCIENCES PVT. LTD, Hebei Xingang Pharmaceutical Co., Ltd., Mercator Pharmaceutical Solutions|
|Region/Countries Covered||Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Iran, Thailand, South Korea, Iraq, Saudi Arabia, Malaysia, Nepal, Taiwan, Sri Lanka, UAE, Israel, Hongkong, Singapore, Oman, Kuwait, Qatar, Australia, and New Zealand
Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece
North America: United States and Canada
Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru
Africa: South Africa, Nigeria, Egypt, Algeria, Morocco
|Currency||US$ (Data can also be provided in local currency)|
|Supplier Database Availability||Yes|
|Customization Scope||The report can be customized as per the requirements of the customer|
|Post-Sale Analyst Support||360-degree analyst support after report delivery|
Note: Our supplier search experts can assist your procurement teams in compiling and validating a list of suppliers indicating they have products, services, and capabilities that meet your company's needs.
In this procedure, a Nocardia mediterranei culture is utilised to inoculate a fermentation media made of starch, glucose, starch from soybeans, peanut meal, and other ingredients. The result of the fermentation is rifamycin B, which is then transformed into rifamycin-O, rifamycin-S, rifamycin SV, and lastly rifampicin.
The displayed pricing data is derived through weighted average purchase price, including contract and spot transactions at the specified locations unless otherwise stated. The information provided comes from the compilation and processing of commercial data officially reported for each nation (i.e. government agencies, external trade bodies, and industry publications).
Procurement Resource is a one-stop solution for businesses aiming at the best industry insights and market evaluation in the arena of procurement. Our team of market leaders covers all the facets of procurement strategies with its holistic industry reports, extensive production cost and pre-feasibility insights, and price trends dynamics impacting the cost trajectories of the plethora of products encompassing various industries. With the best analysis of the market trends and comprehensive consulting in light of the best strategic footstep, Procurement Resource got all that it takes.
Procurement Resource has made a mark for itself in terms of its rigorous assistance to its clientele. Our experienced panel of experts leave no stone unturned in ensuring the expertise at every step of our clients' strategic procurement journey. Our prompt assistance, prudential analysis, and pragmatic tactics considering the best procurement move for industries are all that sets us apart. We at Procurement Resource value our clients, which our clients vouch for.
Expertise, judiciousness, and expedience are the crucial aspects of our modus operandi at Procurement Resource. Quality is non-negotiable, and we don't compromise on that. Our best-in-class solutions, elaborative consulting substantiated by exhaustive evaluation, and fool-proof reports have led us to come this far, making us the ‘numero uno' in the domain of procurement. Be it exclusive qualitative research or assiduous quantitative research methodologies, our high quality of work is what our clients swear by.